Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
The patient's disease ... our knowledge of mitochondrial disorders. By shedding light on the function of MICOS10, the study opens new possibilities for genetic testing and treatment development.
To date, approaches to treatments for Alzheimer's disease have not addressed the ... the toxic effects of the aggregates by boosting mitochondrial health. "Based on our discoveries, targeting ...
Study identifies plasma free-carnitine deficiency in women with aMCI and early-AD, highlighting mitochondrial metabolism as a target for individualized preventive treatments. Study: Sex ...
a first-in-class drug targeting mitochondrial dysfunction and marketed in Japan for the treatment of type-2 diabetes. This new patent protects the use of Imeglimin for type-2 diabetic patients with ...